Vashisht Gopal Yennu Nanda, Ph.D. Photo courtesy of The University of Texas MD Anderson Cancer Center Researchers at The University of Texas MD Anderson Cancer Center report that tailoring targeted drug combinations to tumour dependence on BCL2 family proteins may restore treatment responses in patients with advanced melanoma that has progressed on standard BRAF-MEK therapy. These personalized strategies may improve outcomes in this challenging patient population and, in addition, potentially...

Photo by BRI72783 via Wikimedia Commons There is greater appreciation of potential comorbidities in patients with hidradenitis suppurativa (HS), both in the adult and pediatric setting, according to a special report in the June 2026 edition of The Chronicle of Skin & Allergy. Comorbidities are common in patients with HS, and some of the most challenging to manage include inflammatory bowel disease, inflammatory arthritis, polycystic ovary syndrome, metabolic syndrome, depression, anxiety,...

Photo by James Heilman, MD via Wikimedia Commons A group of Canadian dermatologists has proposed the first practical “treat-to-target” framework for chronic hand eczema, aiming to bring more structure and predictability to management of a condition that is both common and highly burdensome for patients. The recommendations, published as an open-access brief report in the Journal of the American Academy of Dermatology, come at a time when an expanding range of therapies for chronic hand eczema...